We are live on ! Find out more
CVS icon

CVS Health

1,752 hedge funds and large institutions have $73.4B invested in CVS Health in 2025 Q1 according to their latest regulatory filings, with 277 funds opening new positions, 535 increasing their positions, 758 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more funds holding in top 10

Funds holding in top 10: 1337 (+24)

63% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 170

55% more capital invested

Capital invested by funds: $47.3B → $73.4B (+$26.1B)

5% more funds holding

Funds holding: 1,6681,752 (+84)

2.63% more ownership

Funds ownership: 83.3%85.93% (+2.6%)

7% more call options, than puts

Call options by funds: $2.18B | Put options by funds: $2.05B

29% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 758

Holders
1,752
Holders Change
+84
Holders Change %
+5.04%
% of All Funds
23.49%
Holding in Top 10
37
Holding in Top 10 Change
+24
Holding in Top 10 Change %
+184.62%
% of All Funds
0.5%
New
277
Increased
535
Reduced
758
Closed
170
Calls
$2.18B
Puts
$2.05B
Net Calls
+$135M
Net Calls Change
-$187M
Name Holding Trade Value Shares
Change
Change in
Stake
Lido Advisors
601
Lido Advisors
California
$2.16M -$406K -6,786 -18%
BG
602
Bellevue Group
Switzerland
$2.15M +$593K +9,911 +45%
WIA
603
World Investment Advisors
California
$2.14M -$19.2K -321 -1%
XT
604
XTX Topco
Cayman Islands
$2.14M +$1.89M +31,516 New
FAM
605
Fred Alger Management
New York
$2.13M +$1.88M +31,482 New
FHA
606
Flagship Harbor Advisors
Massachusetts
$2.13M -$3.77K -63 -0.2%
CI
607
CX Institutional
Indiana
$2.11M -$4.17M -69,625 -69%
MAM
608
Mystic Asset Management
Rhode Island
$2.11M -$48.3K -807 -3%
SG
609
StoneX Group
New York
$2.11M +$149K +2,483 +9%
FFS
610
Founders Financial Securities
Maryland
$2.09M +$1.15M +19,285 +149%
PCA
611
Pallas Capital Advisors
Massachusetts
$2.09M +$1.23M +20,480 +197%
PWG
612
Portside Wealth Group
Utah
$2.09M +$237K +3,956 +15%
VFA
613
Valeo Financial Advisors
Indiana
$2.07M +$91.7K +1,532 +5%
PA
614
Procyon Advisors
Connecticut
$2.07M +$1.82M +30,482 New
BDPWM
615
Barnes Dennig Private Wealth Management
Ohio
$2.06M +$1.82M +30,474 New
CNFG
616
Creegan & Nassoura Financial Group
New Hampshire
$2.06M
CPA
617
Court Place Advisors
Maryland
$2.06M -$106K -1,763 -5%
PIMJS
618
PKO Investment Management Joint-Stock
Poland
$2.05M -$898K -15,000 -33%
JCM
619
Jacobi Capital Management
Pennsylvania
$2.05M +$78.8K +1,317 +5%
ACM
620
Argyle Capital Management
Pennsylvania
$2.05M +$53.9K +900 +3%
SC
621
Searle & Co
Connecticut
$2.04M -$2.39K -40 -0.1%
SC
622
Savant Capital
Illinois
$2.04M -$334K -5,585 -16%
TCM
623
Tandem Capital Management
New Jersey
$2.03M +$461K +7,698 +34%
RC
624
RBF Capital
California
$2.03M +$1.8M +30,000 New
CIC
625
Cornercap Investment Counsel
Georgia
$2.01M +$1.78M +29,689 New

CVS Hedge Fund Activity: Q1 2025 in Review

1,752 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2025, worth a combined $73.4B — up 55% from $47.3B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 170 closed out — a net gain of 107 holders — while 535 added to existing stakes and 758 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $971M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $309M.

  • 1,752 institutional investors held CVS Health (CVS) as of Q1 2025, up from 1,668 in Q4 2024.
  • Funds reported $73.4B of CVS Health stock for Q1 2025, up 55% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q1 2025 and 170 closed out, a net change of +107 holders.
  • The largest CVS Health buyer in Q1 2025 was Capital Research Global Investors, an estimated $971M added.
  • The largest CVS Health seller in Q1 2025 was Hotchkis & Wiley Capital Management, an estimated $309M sold.

Based on aggregated 13F filings for Q1 2025.